跳至主要内容
临床试验/ACTRN12618000203257
ACTRN12618000203257撤回未知

Effectiveness of a porous titanium and hydroxyapatite plasma-sprayed short stem in total hip arthroplasty.

MAC Surgical0 个研究点目标入组 222 人开始时间: 2018年2月8日最近更新:
适应症

试验速览

阶段
未知
状态
撤回
发起方
入组人数
222

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 75 Years(—)
性别
All

入选标准

  • Participants with symptomatic arthritis who are candidates for a primary total hip replacement with an uncemented femoral stem as determined jointly by the surgeon and the patient
  • Age - 75 years or less
  • Patients who understand the conditions of the study and are willing to participate for the length of the prescribed follow-up period

排除标准

  • Patients with rheumatoid arthritis
  • Patients with a history of active infection
  • Patients with conditions or medications associated with osteoporosis or osteopenia
  • Pregnant women or those seeking to become pregnant

研究者

发起方
MAC Surgical

相似试验